AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily SignalsNeutral

2696 companies scored · 2026-10-15 run in progress: 5121 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2696 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.82% Total · 30D
Long–short spread +2.51% Strong Buy minus Strong Sell, mean
Median IC 0.20 Spearman · 30D
Rating changes ▲ 459 ▼ 781 vs the previous run
Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

47 companies

Sorted by 30D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 ELTPELITE PHARMACEUTICALS INC /NV/ Life Sciences 0.35 $267M Neutral +1.07% +3.58% ·
2 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.07 $367M Neutral +1.05% +2.26% ·
3 TARSTarsus Pharmaceuticals, Inc. Life Sciences 0.02 $3.2B Neutral +1.05% +3.71% ·
4 ZBIOZenas BioPharma, Inc. Life Sciences 0.17 $1.6B Neutral +1.05% +4.13% ·
5 QDELQuidelOrtho Corp Life Sciences 0.09 $951M Neutral +1.04% +3.53% ▼ 1
6 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.18 $6.1B Neutral +1.03% +2.93% ·
7 CANFCan-Fite BioPharma Ltd. Life Sciences 0.17 $383M Neutral +1.03% +1.28% ·
8 CYRXCryoport, Inc. Life Sciences 0.31 $843M Neutral +1.03% +3.28% ▼ 1
9 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.35 $2.2B Neutral +1.03% +2.87% ·
10 SIGASIGA TECHNOLOGIES INC Life Sciences 0.47 $223M Neutral +1.03% +2.60% ·
11 CGENCOMPUGEN LTD Life Sciences 0.42 $189M Neutral +1.01% +3.15% ·
12 KROSKeros Therapeutics, Inc. Life Sciences 0.25 $219M Neutral +1.00% +3.03% ▼ 1
13 RGENREPLIGEN CORP Life Sciences 0.52 $10.1B Neutral +1.00% +3.08% ▼ 1
14 GMABGENMAB A/S Life Sciences 0.08 $23.7B Neutral +0.98% +2.92% ▼ 1
15 ANABANAPTYSBIO, INC Life Sciences 0.28 $1.5B Neutral +0.97% +2.88% ·
16 SABSSAB Biotherapeutics, Inc. Life Sciences 0.28 $227M Neutral +0.96% +2.94% ▼ 1
17 TLRYTilray Brands, Inc. Life Sciences 0.01 $428M Neutral +0.92% +2.60% ·
18 BBIOBridgeBio Pharma, Inc. Life Sciences 0.17 $12.7B Neutral +0.91% +2.83% ▼ 1
19 HCMHUTCHMED (China) Ltd Life Sciences -0.06 $2.4B Neutral +0.91% +2.75% ·
20 WVEWave Life Sciences, Inc. Life Sciences 0.50 $609M Neutral +0.90% +1.97% ▼ 1
21 NRIXNurix Therapeutics, Inc. Life Sciences 0.37 $2.5B Neutral +0.89% +2.84% ·
22 MSLESatellos Bioscience Inc. Life Sciences 0.36 $102M Neutral +0.88% +2.47% ·
23 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.12 $13.3B Neutral +0.87% +2.58% ·
24 RPRXRoyalty Pharma plc Life Sciences 0.59 $33.9B Neutral +0.84% +2.96% ·
25 NBPNovaBridge Biosciences Life Sciences 0.39 $148M Neutral +0.82% +2.82% ·
26 NWBONORTHWEST BIOTHERAPEUTICS INC Life Sciences 0.00 $270M Neutral +0.82% +2.36% ·
27 IRWDIRONWOOD PHARMACEUTICALS INC Life Sciences 0.20 $595M Neutral +0.81% +2.80% ▼ 1
28 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.31 $31.3B Neutral +0.80% +2.40% ·
29 AMRNAMARIN CORP PLC\UK Life Sciences 0.11 $243M Neutral +0.80% +2.36% ·
30 OMEROMEROS CORP Life Sciences 0.29 $1.3B Neutral +0.80% +2.78% ·
31 INSMINSMED Inc Life Sciences 0.17 $21.4B Neutral +0.77% +2.36% ▲ 1
32 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral +0.76% +3.08% ·
33 VTRSViatris Inc Life Sciences 0.36 $20.0B Neutral +0.76% +2.44% ·
34 MGTXMeiraGTx Holdings plc Life Sciences 0.17 $904M Neutral +0.75% +2.61% ▼ 1
35 MDWDMediWound Ltd. Life Sciences 0.25 $153M Neutral +0.73% +1.74% ▲ 1
36 NAGENiagen Bioscience, Inc. Life Sciences 0.34 $200M Neutral +0.73% +2.54% ▼ 1
37 RIGLRIGEL PHARMACEUTICALS INC Life Sciences 0.12 $875M Neutral +0.73% +2.40% ·
38 USNAUSANA HEALTH SCIENCES INC Life Sciences 0.59 $282M Neutral +0.73% +1.91% ·
39 RADXRadiopharm Theranostics Ltd Life Sciences 0.23 $2.6B Neutral +0.72% +0.32% ▲ 1
40 QGENQIAGEN N.V. Life Sciences 0.01 $9.9B Neutral +0.71% +2.24% ▲ 1
41 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.05 $1.9B Neutral +0.67% +2.14% ▲ 1
42 BHCBausch Health Companies Inc. Life Sciences 0.26 $2.2B Neutral +0.67% +2.33% ▼ 1
43 UTHRUNITED THERAPEUTICS Corp Life Sciences 0.22 $23.2B Neutral +0.62% +0.93% ▲ 1
44 MOLNMOLECULAR PARTNERS AG Life Sciences 0.04 $147M Neutral +0.61% +2.29% ▲ 1
45 ARDXARDELYX, INC. Life Sciences 0.27 $815M Neutral +0.60% +2.12% ▼ 1
46 CRMDCorMedix Inc. Life Sciences 0.08 $576M Neutral +0.60% +2.15% ·
47 ZTSZoetis Inc. Life Sciences 0.28 $31.1B Neutral +0.60% +0.28% ▲ 1
Since the previous run

Rating changes

▲ 459▼ 781
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.